Hello,

Here's the first draft of the main paper outline and the main figures/tables - the way I see it at the moment. I want to highlight that this is still very preliminary, but I think it's useful to think about the structure and messages of the paper and put some placeholders. We're going have a very cool paper out of this project, no doubt about that :-)

Only writing this outline I truly realized how much material and exciting results we (will) have. We'll be limited by space though, and it will be difficult to present everyone's results in the length that they'd deserve in the main text/figures. My current, preliminary assignment of the main figures is based on what I know/anticipate of the results at the moment, how they reflect the unique properties of this dataset, novelty/scoopability, and how well they work as selling points to journals.

In order to stay on some kind of schedule, we all (myself included) need to wrap up the analyses in about 2 weeks.

I expect lots of comments and updates - I definitely need your help understanding the key messages and best ways to present your analyses.

cheers,
Tuuli


Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen@unige.ch
On /26/912 21:56 PM, Tuuli Lappalainen wrote:
Hello,

We'll have our regular Geuvadis RNAseq analysis group call on September 27th at 2pm CET.

Agenda:
- agenda for the whole group call within 2 weeks
- presentations in Santiago de Compostela
- draft of the main paper outline by Tuuli
    - we need to come up with a good common statistics (or two) to describe population variation of different transcriptome features
- Manny will presentation on loff-of-function splice variant effects


Call details:
Germany         +49 692 573 804 41
Netherlands         +31 108 920 271
Spain         +34 931 816 661
Sweden         +46 840 309 949
Switzerland         +41 58 262 07 22
United Kingdom         +44 203 370 57 19
United States         +1 646 381 08 89
Access code: 611683

best regards,
Tuuli

-- 
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen@unige.ch


_______________________________________________
Geuvadis_rna_analysis mailing list
Geuvadis_rna_analysis@lists.crg.es
http://davinci.crg.es/mailman/listinfo/geuvadis_rna_analysis